These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol. Au BT, Teixeira MM, Collins PD, Williams TJ. Br J Pharmacol; 1998 Mar; 123(6):1260-6. PubMed ID: 9559913 [Abstract] [Full Text] [Related]
30. Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Prabhakar U, Lipshutz D, Bartus JO, Slivjak MJ, Smith EF, Lee JC, Esser KM. Int J Immunopharmacol; 1994 Oct; 16(10):805-16. PubMed ID: 7843852 [Abstract] [Full Text] [Related]
32. Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock. Badger AM, Olivera DL, Esser KM. Circ Shock; 1994 Dec; 44(4):188-95. PubMed ID: 7628060 [Abstract] [Full Text] [Related]
36. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts. Marko D, Romanakis K, Zankl H, Fürstenberger G, Steinbauer B, Eisenbrand G. Cell Biochem Biophys; 1998 Dec; 28(2-3):75-101. PubMed ID: 9515161 [Abstract] [Full Text] [Related]
37. Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor. Eigler A, Matschke V, Hartmann G, Erhardt S, Boyle D, Firestein GS, Endres S. J Leukoc Biol; 2000 Jul; 68(1):97-103. PubMed ID: 10914495 [Abstract] [Full Text] [Related]